Parameter | Value for the Netherlands | Value for a reference cancer centre | Source |
---|---|---|---|
Cancer incidence in the Netherlands: | |||
2015 | 110,215 | 6,533 | Signaleringscommissie Kanker of the Dutch Cancer Society, 2011 [4] |
2016 | 112,776 | 6,675 | |
2017 | 115,337 | 6,816 | |
2018 | 117,899 | 6,805 | |
2019 | 120,460 | 7,097 | |
2020 | 123,021 | 6,237 | |
Percentage of eligible patients: | |||
% with 5-year survival | 62 % | Dutch Cancer Registry [15] | |
% aged 25–64 | 40 % | Dutch Cancer Registry [14] | |
% with treatment outcome that allows | 80 % | Assumption | |
RTW | |||
% who want to resume work | 85 % | Assumption | |
% who wish to follow intervention | 70 % | Assumption | |
% eligible for intervention | 12 % (=1*0.32*0.80*0.85*0.70) | Product of the above | |
Capacity in current practice: | |||
2015 | 5 % | 5 % | Assumptions |
2015 | 5 % | 5 % | |
2016 | 5 % | 5 % | |
2017 | 5 % | 5 % | |
2018 | 5 % | 5 % | |
2019 | 5 % | 5 % | |
2020 | 5 % | 5 % | |
Capacity in new situation: | |||
2015 | 20 % | 30 % | Assumptions |
2016 | 30 % | 60 % | |
2017 | 40 % | 90 % | |
2018 | 50 % | 90 % | |
2019 | 60 % | 90 % | |
2020 | 70 % | 90 % | |
Percentage of patients for whom the intervention is reimbursed in current situation: | 100 % | ||
Percentage of patients for whom the intervention is reimbursed in new situation: | 10 % | Assumption | |
Intervention costs | € 1,517 | Assessment of the costs based on intervention description [13] and information provided from the staff who delivered the intervention. | |
Additional weekly working hours in the new situation | 5.8 h | Thijs et al., 2011 [17] |